Common use of high doses of antipsychotic medications in older Asian patients with schizophrenia (2001-2009)

International Journal of Geriatric Psychiatry

Volumn 29, Issue 4, 2014, Pages 359-366

  Xiang, Yu Tao ^a,b   Li, Yan ^a   Correll, Christoph U ^c   Ungvari, Gabor S ^d,e   Chiu, Helen F K ^a   Lai, Kelly Y C ^a   Tang, Quan Sheng ^f,g   Hao, Wei ^f   Si, Tian Mei ^h   Wang, Chuan Yue ^b   Lee, Edwin H M ⁱ   He, Yan Ling ^j   Yang, Shu Yu ^k   Chong, Mian Yoon ^l   Kua, Ee Heok ^m   Fujii, Senta ⁿ   Sim, Kang ^o   Yong, Michael K H ^p   Trivedi, Jitendra K ^q   Chung, Eun Kee ^r   Udomratn, Pichet ^s   Chee, Kok Yoon ^t   Sartorius, Norman ^u   Tan, Chay Hoon ^m   Shinfuku, Naotaka ^v   more..

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Division of Psychiatry Research Zucker Hillside Hospital North Shore Long Island Jewish Health System ^*  (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF NOTRE DAME   (Australia)

^f CENTRAL SOUTH UNIVERSITY   (China)

^g Nanning Red Cross Hospital   (China)

^h PEKING UNIVERSITY SIXTH HOSPITAL   (China)

ⁱ UNIVERSITY OF HONG KONG   (Hong Kong)

^j SHANGHAI MENTAL HEALTH CENTER   (China)

^k TAIPEI CITY HOSPITAL   (Taiwan)

^l CHANG GUNG UNIVERSITY   (Taiwan)

^m NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁿ Hyogo Institute for Traumatic Stress HITS   (Japan)

^o INSTITUTE OF MENTAL HEALTH   (Singapore)

^p ALEXANDRA HOSPITAL   (Singapore)

^q KING GEORGE'S MEDICAL UNIVERSITY   (India)

^r National Seoul Hospital   (South Korea)

^s PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^t HOSPITAL KUALA LUMPUR   (Malaysia)

^u Association for the Improvement of Mental Health Programs   (Switzerland)

^v SEINAN GAKUIN UNIVERSITY   (Japan)

more..

Author keywords

Asia; high dose; older patients; prescription patterns; schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; ZOTEPINE;

ADULT; AGED; ARTICLE; ASIAN; CHINA; DISEASE DURATION; DRUG MEGADOSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HONG KONG; HOSPITAL PATIENT; HUMAN; JAPAN; KOREA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCRIPTION; SCHIZOPHRENIA; SINGAPORE; TAIWAN; TARDIVE DYSKINESIA; VERY ELDERLY;

ASIA; HIGH DOSE; OLDER PATIENTS; PRESCRIPTION PATTERNS; SCHIZOPHRENIA;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SCHIZOPHRENIA; SOCIOECONOMIC FACTORS;

EID: 84895804196     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4011     Document Type: Article

References (37)

1. Alexopoulos GS, Streim J, Carpenter D, Docherty JP,. 2004. Using antipsychotic agents in older patients. J Clin Psychiatry 65 (Suppl 2): 5-99; discussion 100-102; quiz 103-104.
2. Alvarez GG, Ayas NT,. 2004. The impact of daily sleep duration on health: a review of the literature. Prog Cardiovasc Nurs 19: 56-59.
3. APA. 1997. Practice Guideline for the Treatment of Patients with Schizophrenia. Washington, DC: American Psychiatric Press.
4. Ayas NT, White DP, Manson JE, et al., 2003. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163: 205-209.
5. Buchanan RW, Kreyenbuhl J, Kelly DL, et al., 2010. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 36: 71-93.
6. Byerly M, Suppes T, Tran QV, Baker RA,. 2007. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives. J Clin Psychopharmacol 27: 639-661.
7. Chiu HF, Shum PS, Lam CW,. 1991. Psychotropic drug prescribing to chronic schizophrenics in a Hong Kong hospital. Int J Soc Psychiatry 37: 187-191.
8. Chong MY, Tan CH, Shinfuku N, et al., 2010. Prescribing antipsychotic drugs for inpatients with schizophrenia in Asia: comparison of REAP-2001 and REAP-2004 studies. Asia-Pac Psychiatry 2: 77-84.
9. Correll CU, Leucht S, Kane JM,. 2004. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161: 414-425.
10. Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S,. 2009. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 35: 443-457.
11. Dassori AM, Copeland LA, Zeber JE, Miller AL,. 2011. Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia. Psychiatr Serv 62: 47-53.
12. Frackiewicz EJ, Sramek JJ, Herrera JM, Kurtz NM, Cutler NR,. 1997. Ethnicity and antipsychotic response. Ann Pharmacother 31: 1360-1369.
13. Fujii S, Shinfuku N,. 2005. Utilization of levomepromazine in Japan-its role as an antipsychotic in psychiatric pharmacotherapy (in Japanese). Rinsyo Seisin Yakuri 8: 1227-1238.
14. Gallego JA, Bonetti J, Zhang J, Kane JM, Correll CU,. 2012. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res 138: 18-28.
15. Gottlieb DJ, Punjabi NM, Newman AB, et al., 2005. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165: 863-867.
16. Gottlieb DJ, Redline S, Nieto FJ, et al., 2006. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 29: 1009-1014.
17. Honer WG, MacEwan GW, Gendron A, et al., 2012. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. J Clin Psychiatry 73: 13-20.
18. Ji ZF,. 2005. Evaluation and analysis of drug-use in hospitals of China. Eval clin usage partial dopamine recept agonist (in Chinese) 5: 89-91.
19. Kane JM, Aguglia E, Altamura AC, et al., 1998. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol 8: 55-66.
20. Kinon BJ, Volavka J, Stauffer V, et al., 2008. Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study. J Clin Psychopharmacol 28: 392-400.
21. Kishimoto T, Watanabe K, Uchida H, Mimura M, Kane JM, Correll CU,. 2013. Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales. Psychiatry Res. 2013 Apr 18. [Epub ahead of print]; DOI: 10.1016/j.psychres.2013.03.014.
22. Kohen I, Lester PE, Lam S,. 2010. Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole. Neuropsychiatr Dis Treat 6: 47-58.
23. Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB,. 2010. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull 36: 94-103.
24. Lindenmayer JP, Citrome L, Khan A, Kaushik S,. 2011. A randomized, double-blind, parallel-group, fixed-dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder. J Clin Psychopharmacol 31: 160-168.
25. Masand PS,. 2000. Side effects of antipsychotics in the elderly. J Clin Psychiatry 61 Suppl 8: 43-49.
26. Merecz D, Rymaszewska J, Moscicka A, Kiejna A, Jarosz-Nowak J,. 2006. Violence at the workplace-a questionnaire survey of nurses. Eur Psychiatry 21: 442-450.
27. Meyers BS, Jeste DV,. 2010. Geriatric psychopharmacology: evolution of a discipline. J Clin Psychiatry 71: 1416-1424.
28. Pierre JM,. 2005. Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management. Drug Saf 28: 191-208.
29. Shinfuku N, Tan CH,. 2008. Pharmacotherapy for schizophrenic inpatients in East Asia-changes and challenges. Int Rev Psychiatry 20: 460-468.
30. Sim K, Su HC, Fujii S, et al., 2009. High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies. Br J Clin Pharmacol 67: 110-117.
31. Uchida H, Mamo DC, Mulsant BH, Pollock BG, Kapur S,. 2009a. Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms. J Clin Psychiatry 70: 397-405.
32. Uchida H, Pollock BG, Bies RR, Mamo DC,. 2009b. Predicting age-specific dosing of antipsychotics. Clin Pharmacol Ther 86: 360-362.
33. Ungvari GS, Chung YG, Chee YK, Fung-Shing N, Kwong TW, Chiu HF,. 2002. The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999. Br J Clin Pharmacol 54: 437-444.
34. Webb WB, Agnew HW,. 1975. Are we chronically sleep deprived? Bull Psychon Soc 6: 47-48.
35. WHO. 2005 WHO Mental Health Atlas 2005. Geneva: World Health Organization.
36. WHO Collaborating Centre for Drug Statistic Methodology. 2002. Guidelines for ATC Index with DDDs. Oslo: WHO.
37. Woods SW,. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64: 663-667.